RxDoctor Payments Data

Taurean Baynard, MD

Adult Reconstructive Orthopaedic Surgery · Mesa, AZNPI 1932660768

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (47.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 47.7% of the total. 2025 is the largest year on record at $7,223, 5.9 times the $1,214 reported in 2021.

$15,936in general payments, 2019–2025

Across 52 payments — averaging $306.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$8K
  • Encore Medical, LP$5K
  • Great Lakes Orthopedics$1K
  • Stryker$1K
  • Zimmer Biomet$679
  • Johnson & Johnson$466
  • plus $168 from 2 others

What the payments were for

  • Consulting fees$1,5009%
  • Grants$7,50047%
  • Travel & lodging$2,87018%
  • Food & beverage$2,86618%
  • Education$1,2008%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,936 in reported general payments places this provider in the 65th percentile of 43 adult reconstructive orthopaedic surgery providers in Arizona.

See all adult reconstructive orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$11,350
Medicare patients
28
Services billed
32

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib20$862
Cefadroxil17$145
Oxycodone Hcl21$125

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →